Individual natriuretic and diuretic response in acute heart failure: insights from the PUSH-AHF pharmacological substudy

17 May 2025 (08:00 - 12:45)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Iris Eline Beldhuis

University Medical Centre Groningen, Groningen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Real-world SGLT2i prescribing in an elderly population; a tertiary centre review

Doctor G. O Dea (Limerick, IE)

Abstract Slides Video

Presentation thumbnail

Association between congestion and aspirin resistance in patients with chronic coronary syndrome

Doctor I. Meray (Tyre, LB)

Abstract Slides Video

Presentation thumbnail

Supernormal cardiac function: exercise vs. dapagliflozin

Miss R. Vago (Debrecen, HU)

Abstract Slides Video

Presentation thumbnail

The PCSK9 targeted therapy - the best strategy to prevent cardiovascular complications in very high-risk patients in poland. Real-life data from the national health found B101 reimbursement program

Professor M. Banach (Lodz, PL)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in pharmacology and pharmacotherapy

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025

You may be interested in

Congress Presentation

The dynamics of urine sodium concentration after intra-venous furosemide in patients with acute heart failure

Congress Presentation

Loop diuretic use before an acute heart failure hospitalization drives natriuretic response but not the efficacy of natriuresis-guided diuretic therapy, a prespecified analysis from the PUSH-AHF trial

Congress Presentation

The early evaluation of diuretic resistance as recommended by ESC Guidelines predicts long-term outcomes in patients with acute heart failure.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources